Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dbrg77
    Junior Member
    • Sep 2010
    • 6

    Anyone using Bioruptor Pico?

    Hi,

    I'm wondering whether anyone here has ever succeeded using Bioruptor Pico sonicator for transcription factor ChIP-qPCR.

    Before, we had an old standard Bioruptor which worked okay with both ChIP-qPCR and ChIP-seq. Recently, we've switched to the new product from Diagenode, i.e. Bioruptor Pico. When we look at the input sample on agarose gel, it suggests that the new sonicator is very efficient for chromatin shearing (if using their special tubes from Diagenode).

    However, I am currently unable to perform a successful ChIP-qPCR (no enrichment, Ct of ChIP samples is very very high).

    I'm sure both the protocol and antibodies are fine, as we have been doing ChIP-qPCR and ChIP-seq for years without any problem using the same procedure, except, of course, the sonicator.

    I ran my input sample and IPs on western blot, the strange thing is that I cannot even detect my TF in the input sample ......

    I am wondering whether anybody here has the same problem, or anybody is using this sonicator without any problems.

    Thank you.
  • richi17
    Junior Member
    • Mar 2014
    • 2

    #2
    Hi,
    We were able to generate nice ChIP-seq data comparable to ENCODE using CTCF, p300 and LSD1. We have noticed that ChIP recovery (% of input) drops slightly on chromatin shared on Pico but at the same time the fold enrichment (ratio pos/neg loci) is usually higher compared to chromatin sheared on old Bioruptors.
    Comparing to an old Biorupotrs, Bioruptor Pico is a way more performant. Consequently, a sonication protocol should be re-adapted to Pico by decreasing a sonication time. Usually, 5-10 cycles are already enough for an efficient shearing with fragments in the range 100-300 bp (an ideal range for ChIP-seq) . In some cells type, even shorter sonication time (2-3 cycles) resulted in a nice shearing. It is important to perform a pilot experiment before ChIP to figure out how long to sonicate. The golden rule is always to choose the shortest sonication. For some antibodies, it is worth trying a longer fixation (15-20 min). Regarding ChIP-qPCR, primers sets should be revised and primers amplifying short PCR products (80-100 bp) should be preferred. Longer PCR products could lead to reduced sensitivity in qPCR.

    Diagenode-Bioruptor Pico

    Comment

    • dbrg77
      Junior Member
      • Sep 2010
      • 6

      #3
      Originally posted by richi17 View Post
      Hi,
      We were able to generate nice ChIP-seq data comparable to ENCODE using CTCF, p300 and LSD1. We have noticed that ChIP recovery (% of input) drops slightly on chromatin shared on Pico but at the same time the fold enrichment (ratio pos/neg loci) is usually higher compared to chromatin sheared on old Bioruptors.
      Comparing to an old Biorupotrs, Bioruptor Pico is a way more performant. Consequently, a sonication protocol should be re-adapted to Pico by decreasing a sonication time. Usually, 5-10 cycles are already enough for an efficient shearing with fragments in the range 100-300 bp (an ideal range for ChIP-seq) . In some cells type, even shorter sonication time (2-3 cycles) resulted in a nice shearing. It is important to perform a pilot experiment before ChIP to figure out how long to sonicate. The golden rule is always to choose the shortest sonication. For some antibodies, it is worth trying a longer fixation (15-20 min). Regarding ChIP-qPCR, primers sets should be revised and primers amplifying short PCR products (80-100 bp) should be preferred. Longer PCR products could lead to reduced sensitivity in qPCR.

      Diagenode-Bioruptor Pico
      Thank you for the reply. For some factors, we observed exactly what you said. However, we just cannot chip some other factors. Recently, I run my time-course sonication samples on a western blot together with unsonicated lysate. It turns out the sonication process destroy the epitope of the protein of our interest. You can see the loss of signal as early as 5 min. As a control, we use normal eppendorf tubes which are not very efficient in Bioruptor Pico, it turns out to be okay.

      I guess we need to find a fine balance between efficient sonication and not losing protein.

      Cheers
      Attached Files

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Yesterday, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:10 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      30 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      41 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...